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A unique  non-laying  strain  of chickens  with  heritable  hyperlipidemia  and  aortic  atheroscle-
rosis  was  ﬁrst  described  in  1974.  Subsequent  work  established  that  the  phenotype  results
from a naturally  occurring  point  mutation  in  the  gene  specifying  the  very  low  density
lipoprotein  (VLDL)  receptor,  a 95-kDa  membrane  protein  which  normally  mediates  the
massive uptake  of the  main  circulating  hepatically-synthesized  yolk  precursors,  VLDL  and
vitellogenin.  As a result,  hens  of the  mutant  strain  termed  “restricted  ovulator”  (R/O)  have
approximately  5-fold  elevations  in  circulating  cholesterol  and  triglyceride  concentrations
compared  with  normal  layers,  and  hepatic  lipogenesis  and  cholesterogenesis  are markedly
attenuated  due  to  feedback  inhibition.  R/O  hens  also  exhibit  hyperestrogenemia,  hypopro-
gesteronemia,  elevated  circulating  gonadotropins,  and  up-regulated  pituitary  progesterone
receptor mRNA  and  isoforms.  The  ovaries  of  R/O  hens  are  abnormal  in  that  they  lack  a  follic-
ular hierarchy  and  contain  many  small  preovulatory  follicles  of  various  colors,  shapes,  and
sizes.  However,  since  R/O hens  occasionally  lay eggs,  it is possible  that  endocytic  receptors
other  than  the  VLDL  receptor  may be able  to facilitate  oocyte  growth  and/or  that  yolk  pre-
cursor uptake  can occur  via a nonspeciﬁc  bulk  process.  A  mammalian  model  of impaired
fecundity  with  abnormal  lipoprotein  metabolism  also  has  been  described,  but  different
mechanisms  are  likely  responsible  for its  reproductive  dysfunction.  Nevertheless,  as our
understanding  of  the  molecular  physiology  and  biochemistry  of avian  oocyte  growth  con-
tinues to expand,  in  part due  to  studies  of the  R/O model,  new  analogies  may  emerge
between  avian  and  mammalian  systems,  which  ultimately  could  help  to  answer  important
questions  in  reproductive  biology.© 2012 Elsevier B.V. 
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1. Introduction
A unique strain of hyperlipidemic female White Leghorn
chickens that failed to lay eggs was initially discovered
at DeKalb Agricultural Research, Inc. (DeKalb, IL) in the
early 1970s. All of the hens were the daughters of a
single rooster thought to carry a mutation responsible
for the non-laying condition. The existence of this non-
laying strain was ﬁrst reported in the literature by Ho
et al. (1974).  As compared with wild-type (WT) hens, non-
laying hens had approximately 5-fold higher serum levels
of cholesterol and triglycerides, a slower daily turnover
of cholesterol, attenuated endogenous cholesterol biosyn-
thesis, developed aortic atherosclerosis, and exhibited
abnormal ovarian morphology (Ho et al., 1974). In each of
two separate matings of the original mutant DeKalb rooster
with WT  females, approximately one-half of the offspring
hens failed to lay eggs upon reaching sexual maturity. Thus,
the condition was heritable and it appeared that the rooster
simply carried a mutation causing the abnormal female
phenotype since his reproductive functions, secondary sex
characteristics, and serum lipid levels were normal (dis-
cussed in Section 3). Hence, Ho et al. (1974) referred to
the original rooster and those of subsequent generations
as “carrier roosters”.
Jones et al. (1975) coined the term “restricted ovula-
tor” (R/O) to describe females possessing the mutant gene.
Two years later, McGibbon (1977) provided evidence that
the sterile condition associated with spontaneous follicu-
lar involution was sex-linked and resulted from a single
gene defect at a locus (ro)  on the sex chromosome Z.
In Aves, females are the heterogametic sex; thus, males
are ZZ and hemizygous females are ZW (Hutt, 1964).
Afﬂicted heterozygous (“carrier”) roosters therefore pass
on the mutation in one of their Z chromosomes to one-
half of their male and to one-half of their female progeny.
Although it is theoretically possible to produce a homozy-
gous mutant male by mating a carrier rooster to a mutant
hen that is able to lay eggs, only heterozygous roosters
possessing one WT  allele and one mutant allele for the
ro gene have been obtained for investigational purposes
to date. . .  .  . .  . . . . .  . .  . . .  .  . . .  . . . .  . .  . . . .  .  . . .  .  . . . . . . .  .  . . . . . .  . . .  . . . .  .  . . .  . . . .  . 11
Here, we  provide the ﬁrst comprehensive review cen-
tered on the R/O chicken strain and describe a unique
oviparous vertebrate model of reproductive dysfunction,
which is uniquely positioned at the crossroad of ovarian
follicle/oocyte development and lipoprotein metabolism.
The authors’ interest in the R/O strain dates back to the
late 1980s, when the laboratory of WJS  ﬁrst described the
molecular defect responsible for this dramatically abnor-
mal  phenotype. Subsequent collaborative studies have
further delineated various reproductive, metabolic, and
physiological characteristics of this valuable and useful ani-
mal  model.
The R/O strain was initially housed at DeKalb Agricul-
tural Research (D.G. Jones). Later, colonies were established
at Northern Illinois University (O.A. Schjeide), the Uni-
versity of Illinois (F.A. Kummerow), the University of
Wisconsin-Madison (W.H. McGibbon and J.J. Bitgood), and
Purdue University (RGE). At present, only two R/O colonies
exist world-wide: one at The Pennsylvania State University
(RGE) and the other at the Medical University of Vienna,
Austria (WJS).
2. Reproductive characteristics—hemizygous R/O
females
2.1. Ovarian and oviduct morphology and yolk structure
Ovaries of R/O females tend to resemble those under-
going retrogression in WT  hens (Hutt et al., 1956), and the
follicles never attain mature size (i.e., they do not proceed
from F4 to F1 in the follicular hierarchy). Thus, instead
of containing approximately 6–10 hierarchal (vitellogenic)
follicles in a graduated succession of sizes (8–37 mm)  as
described by Johnson (2000),  R/O ovaries typically con-
tain approximately 15 follicles with a maximal diameter
of around 20 mm (equal to follicles typically classiﬁed as
F4 or F5; Fig. 1). In addition, follicles varying in both color
(from pale yellow to green to chocolate brown) and shape
(some contain multiple nodules and are thus raspberry-
like in appearance) are evident (Ho et al., 1974; Jones et al.,
1975; Grau et al., 1979; Mitchell et al., 1979; Nimpf et al.,
1989; Elkin et al., 2003b; Ocón-Grove et al., 2007; Giles
R.G. Elkin et al. / Animal Reproduction Science 136 (2012) 1– 13 3
Fig. 1. Representative ovaries and blood plasma from sexually mature wild-type (WT) and ‘restricted ovulator’ (R/O) White Leghorn hens. In addition to
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Despite the extreme changes in ovarian morphology,
some R/O females are able to lay eggs (Table 1 and Fig. 2),
although the eggs are generally smaller and have darker
colored yolks than those from the normal hens (Ho et al.,
Table 1
Relative comparison of risk factors for ovarian cancer (OC) in women and
the domestic hen (WT  = wild-type; R/O = restricted ovulator).
Item Womena WT Hensb R/O Hensb
Incidence of OC 1–2% 27% 3%
Lifetime ovulations 400–500c 422 Eggs 28 Eggs
Progesterone Protective Normald Lowere
Estrogen Increases risk Normald Highere
Gonadotropins Increases risk Normald Highere
Adapted from Giles et al. (2010); reproduced with permission from Int. J.
Gynecol. Cancer 20:738–744. Copyright IGCS and ESGO (2010).acking a typical ovarian follicular hierarchy and possessing abnormal fol
 marked accumulation of yolk precursor macromolecules in the circulati
t al., 2010). As compared to WT  layers, R/O hens have
maller oviducts with less active mucous glands (Ho et al.,
974). The latter characteristic was attributed to long-term
isuse and was not considered to be the cause of non-laying
Ho et al., 1974). The lack of other oviductal abnormalities
r of gross pathologic changes in R/O hens was conﬁrmed
y Mitchell et al. (1979).
Within hierarchal follicles that are actively taking up
olk precursor macromolecules from the bloodstream, yolk
eposition within the growing oocyte normally occurs in
oncentric pseudo-spherical shells that do not mix  (Burley
nd Vadehra, 1989). This can be easily visualized either by
eeding fat-soluble dyes to hens or by injecting the dye as a
olloidal dispersion into their blood stream, hard-cooking
or freezing) the eggs, and then preparing a cross-section
f the yolk. Using this method, Birrenkott and McGibbon
1975) and Grau et al. (1979) investigated the yolk ring
tructure of laid eggs from WT  and R/O hens. Based on the
ye deposition pattern, Birrenkott and McGibbon (1975)
eported that yolks from WT  and R/O hens took approx-
mately 8 d and 7 d, respectively, to develop, but they
id not mention whether there was any disruption of the
ormal yolk banding pattern in eggs from R/O hens com-
ared with those from WT  hens. In contrast, Grau et al.
1979) observed rings in the yolk of hierarchal follicles of
/O hens but, in laid R/O eggs, the yolk ring structure was
ompletely disrupted. This suggested that the yolk struc-
ure of R/O eggs was not as stable as that of eggs from WT
ens. Although the underlying cause of this phenomenonvarying shapes and colors, R/O blood plasma is extremely lipemic due to
is unknown, Grau et al. (1979) found that yolks of R/O
eggs contained 16% more water than WT  egg yolks, while
Schjeide et al. (1975) observed a paucity of maturing yolk
granules in the ooplasm of small hierarchal follicles (5 mm
in diameter) of R/O hens.
2.2. Egg production and yolk protein proﬁlesa Data from Riman et al. (1998).
b Data from Giles et al. (2010).
c Approximate number.
d Plasma levels of hormones.
e Plasma levels of hormones relative to WT  hens.
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Fig. 2. Egg production of the daughters of mutant ‘restricted ovulator’
(R/O) sires. Individual egg production was monitored for either four or
ﬁve  PCR-genotyped daughters from each of 11 PCR-genotyped mutant
(heterozygous) R/O sires for 331 d. During this period, the 27 wild-type
(WT) daughters laid an average (±SD) of 255 ± 45 eggs, while the 26 R/O
Fig. 3. SDS-PAGE (4.5–18% gradient) gel of whole yolk extracts from
a wild-type (WT) and a ‘restricted ovulator’ (R/O) hen stained with
Coomassie Brilliant Blue R-250. Protein standard molecular weights are
indicated. Lanes 1 and 2 contained yolk extracts of two  eggs from a WT
hen; lanes 3 and 4 contained yolk extracts of two eggs from an R/O hen
that  laid 46 eggs/331 d (a daughter of sire 4 in Fig. 2). Each lane containeddaughters averaged 6 ± 9 eggs laid.
From Elkin et al. (2003b); reproduced with permission from Poultry Sci-
ence 82:517–525. Copyright Poultry Science Association, Inc. (2003).
1974; Jones et al., 1975; Birrenkott and McGibbon, 1975;
Schjeide et al., 1976; Mitchell et al., 1979; Grau et al., 1979;
Cho, 1981; Michel et al., 1984; Smith and Kummerow,
1988; Elkin et al., 2003b; Giles et al., 2010). Elkin et al.
(2003b) reported that the SDS-PAGE proﬁles of yolk pro-
teins from two eggs each from a WT  hen and an R/O hen that
laid 46 eggs in 331 d were very similar in terms of band-
ing pattern (Fig. 3). However, in one of the R/O eggs, the
cathepsin D-mediated proteolysis of the major yolk pro-
tein precursors, namely apolipoprotein B and vitellogenin
(VTG) (Burley and Vadehra, 1989; Retzek et al., 1992),
appeared to be somewhat incomplete. Overall, a change in
the yolk protein proﬁle per se is probably not responsible
for the unstable yolk structure of laid R/O eggs described
above.
2.3. Reproductive hormones and receptorsBirrenkott (1975) hypothesized that the R/O pheno-
type was caused by an aberration in the hypothalamus
or pituitary. Although he observed a normal response12 g of protein.
From Elkin et al. (2003b); reproduced with permission from Poultry Sci-
ence 82:517–525. Copyright Poultry Science Association, Inc. (2003).
in circulating LH levels following the injection of R/O
hens with GnRH, this did not rule out a problem at the
hypothalamus. Plasma FSH levels were not determined.
Birrenkott et al. (1975) also reported that plasma LH levels
were signiﬁcantly higher in R/O females as compared with
their WT  siblings, while progesterone values were similar
between the two groups. Although many of the WT hens
had 17-estradiol concentrations that were below the
sensitivity limit of the assay (5 pg/mL), the majority of
the R/O hen plasma samples fell within the range of the
standard curve. Birrenkott et al. (1975) suggested that
the altered rates of hormone production or degradation
might be responsible for the suppressed ovulation in R/O
hens. However, subsequent molecular studies (discussed
in Section 4) did not support this hypothesis.
In chickens, the basal estrogen (estra-
diol + estrone):progesterone ratio is a good predictor
of ovulatory frequency (Leszczynski et al., 1984). Schjeide
et al. (1976) reported an approximate 3-fold elevation in
circulating estradiol and estrone in serum from R/O hens
compared with that from normal layers (19 ng/100 mL  and
25 ng/100 mL  vs. 8 ng/100 mL  and 8 ng/100 mL,  respec-
tively). They also mentioned that (unpublished) work
at the University of Wisconsin had been unsuccessful
in restoring normal ovarian function in R/O hens with
hormone supplementation. Toda et al. (1983) conﬁrmed
the ﬁndings of Schjeide et al. (1976) with regard to 3-fold
higher plasma estrogen levels in R/O hens compared with
WT hens (approximately 30 ng/100 mL  vs. 10 ng/100 mL,
respectively), and also reported that the former had
approximately 3-fold lower progesterone concentra-
tions than WT  hens (40 ng/100 mL  vs. 140 ng/100 mL,
roductio
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espectively). Leszczynski et al. (1984) observed that
/O hens had a plasma estrogen:progesterone ratio that
as 12.6 times higher than normal and resulted from
-fold higher levels of estrogen and 4-fold lower levels
f progesterone, as compared with WT  layers. Moreover,
/O females did not exhibit any cycle-related variation in
irculating progesterone levels and had smaller primary
ex organs. This is in keeping with the observations that
n chickens, almost all of the progesterone is secreted by
nly the most mature preovulatory (hierarchal) follicle
Johnson, 2000) and that the follicles of R/O hens typically
ever attain a size greater than F4 or F5 (Fig. 1).
Ocón-Grove et al. (2007) reported that, as compared
ith WT  hens, R/O hens had an increased abundance of
ituitary progesterone receptor (PR) mRNA and PR iso-
orms A and B (the two major PR variants expressed in the
hicken), signiﬁcantly elevated levels of plasma LH, FSH,
strone, and estradiol, and markedly attenuated levels of
irculating progesterone. In mice, the PR has been shown to
e essential for generating gonadotropin surges (Chappell
t al., 1999). Ocón-Grove et al. (2007) hypothesized that
he upregulation of PR mRNA and PR isoforms A and B was
ost likely a result of the marked hyperestrogenemia and
ypoprogesteronemia, a hallmark of R/O hens. In addition,
hey suggested that the increased levels of circulating FSH
n the mutant hens could have resulted from the lack of
egative feedback inhibition from the ovary in the form
f lower inhibin secretion. The lower plasma progesterone
bserved in R/O hens may  have facilitated the secretion
f GnRH (Ocón-Grove et al., 2007) or removed inhibition
f a hypothalamic factor(s) responsible for increasing LH
ecretion from the pituitary gland.
.4. Incidence of ovarian cancer
Because many cases are diagnosed at an advanced stage
nd the prognosis is poor, epithelial-derived ovarian cancer
OC) is the most fatal human gynecologic malignancy (Giles
t al., 2010). In general, most animals do not spontaneously
evelop OC, although some avian species (including chick-
ns) have a high incidence of ovarian neoplasms (Giles
t al., 2010). The etiology of this malignancy is poorly
nderstood, but one hypothesis proposes that an increased
isk of OC is associated with increased ovulations (Fathalla,
971), as the traumatized epithelium of ruptured follicles is
epeatedly repaired and exposed to estrogen-rich follicular
uid (Riman et al., 1998).
The fact that R/O hens generally fail to ovulate may
uggest that they would be less susceptible to developing
C if the “incessant ovulation” hypothesis of Fathalla
1971) holds true. However, R/O hens also exhibit a hor-
onal proﬁle that is associated with an increased risk of
eveloping OC (i.e., high circulating levels of estrogen and
onadotropins, with low levels of progesterone; Riman
t al., 1998). Therefore, by taking advantage of a unique
nimal model (i.e., the R/O mutant hen), the relationship
etween OC and hormones in the absence of physical
rauma to the ovarian surface epithelium (caused by ovu-
ation) could be unambiguously assessed. In this regard,
iles et al. (2010) observed that only 1 of 31 R/O hens was
iagnosed with OC as compared to 9 of 33 of their WTn Science 136 (2012) 1– 13 5
siblings (Table 1). This strongly suggested that in chickens,
the number of ovulatory events is directly related to the
incidence of OC. However, within the population of WT
hens, evidence for a relationship between egg production
and the incidence of OC was  less obvious, although WT
hens that developed OC laid a greater percentage of their
eggs earlier in life (Giles et al., 2010).
3. Reproductive characteristics—heterozygous
(‘carrier’) males
Based upon initial evaluations of roosters that carried
the abnormal ro gene, Ho et al. (1974) determined that
they were phenotypically normal in terms of reproductive
ability, secondary sex characteristics, serum lipid concen-
trations, and reproductive tract anatomy. However, Ho
et al. (1974) did not provide any supporting data, did not
state upon what basis reproductive ability was assessed,
and did not indicate how many roosters were evaluated. In
an attempt to quantify the fertility and reproductive abili-
ties of 11 heterozygous R/O carrier roosters and 18 of their
WT  siblings, Elkin and Zhong (2002) conducted a breed-
ing trial. Individual semen samples were collected once
weekly from the 29 males and used to artiﬁcially insem-
inate two  hens each per rooster for 4 wk  (roosters were
37–40 wk  of age). The hens were from an unrelated line
of White Leghorn chickens and had a documented rate of
lay in excess of 80%. A total of 765 and 477 eggs were incu-
bated from all matings of the WT  and R/O sires, respectively,
equating to approximately 21 eggs from each mating triad.
There was  no effect of rooster genotype on fertility, hatch-
ability of fertile eggs, and hatchability of all eggs set, which
averaged approximately 77%, 93%, and 71%, respectively.
Although chicks from WT  sire matings were, unexplain-
ably, 1 g heavier than those from R/O matings (38 g vs. 37 g,
respectively; P < 0.05), Elkin and Zhong (2002) considered
the reproductive function of R/O sires to be normal, thus
conﬁrming the earlier qualitative statements of Ho et al.
(1974).
4. Molecular characterization of the R/O mutation
Information on any of the proteins involved in oocyte
growth and systemic lipoprotein transport in the laying
hen was  lacking until 1989, when it was demonstrated that
the absence of a 95-kDa protein in R/O hens is responsi-
ble for the impaired uptake of VLDL into oocytes in-vivo
and, consequently, for the failure of oocytes to develop nor-
mally (Nimpf et al., 1989). Stifani et al. (1990) subsequently
showed that this single 95-kDa protein in the plasma mem-
brane of the oocyte also served as a receptor for VTG, the
other major yolk lipoprotein.
4.1. Identiﬁcation of a point mutation in the VLDL/VTG
receptor (LR8)
The ligand speciﬁcity, as well as the immunological
cross-reactivity of the protein with antibodies against
the human LDL receptor and the calcium requirement
for ligand binding, predicted that it was a homologue of
mammalian LDL receptors (LDLRs). The LDLR and relatives
roductio6 R.G. Elkin et al. / Animal Rep
thereof (the group of receptors is designated LR, for LDLR
relatives) comprises a large number of genes whose prod-
ucts contain a characteristic set of structural domains (for
details, see Schneider and Nimpf, 2003). Attempts to delin-
eate the evolutionary history of this gene family must take
into consideration their wide range of functions, which
include the binding to the extracellular domains of an ever
growing list of ligands, ligand uptake through clathrin-
mediated mechanisms, and signal transduction via the
cytoplasmic regions of the receptors (Stolt and Bock, 2006).
Knowledge gained in studies about the LR gene family in
the chicken has provided major new insights into the biol-
ogy of these receptors, both in structural and functional
terms (Schneider et al., 1997).
Molecular cloning of the cDNA specifying the 95-kDa
oocyte protein indeed revealed that it is an LR containing a
multifunctional ligand binding domain (Bujo et al., 1994).
In contrast to the ligand binding domain of the LDLR, which
consists of 7 tandemly arranged so-called binding repeats,
the chicken receptor’s binding domain was found to con-
tain 8 such repeats. In addition to VLDL and VTG (Stifani
et al., 1990; Barber et al., 1991), the receptor was shown to
bind riboﬂavin-binding protein complexed with VTG (Mac
Lachlan et al., 1994), clusterin (apolipoprotein J; Mahon
et al., 1999), and apolipoprotein E (apoE), a mammalian
apolipoprotein with homology to VTG (Steyrer et al., 1990).
The avian receptor was subsequently named LR8 (LR with 8
ligand binding repeats) in order to distinguish it from mam-
malian “VLDL receptors” that had been reported to bind
VLDL (Takahashi et al., 1992). The gene for LR8 is designated
Gallus gallus VLDLR (NCBI CAA56505) and is located on the Z
chromosome (Bujo et al., 1994; Nanda et al., 2000). The R/O
allele carries a point mutation (G to C substitution), which
results in the replacement of Cysteine-682 with a serine
in the extracellular domain of LR8. Interestingly, the ﬁrst
ever delineated mutation in the human LDLR gene caus-
ing familial hypercholesterolemia occurred exactly in the
equivalent position. The disruption of a disulﬁde bond by
the loss of the cysteine residue due to this mutation was
shown to lead to misfolding of the protein accompanied
by rapid intracellular degradation of the altered receptor
molecules (Leitersdorf et al., 1990). As a consequence, LR8
does not reach the plasma membrane of oocytes of R/O
hens, and is unable to mediate the uptake of serum-derived
yolk precursor molecules.
Although it is quite surprising that oocytes of R/O hens
enter the hierarchal stage of oocyte growth at all, there are
at least two possible explanations for this occurrence. One
is based on the facile access of the oocyte surface to the
serum compartment, as (i) the endothelium of capillar-
ies in the follicular wall displays extensive fenestration
(Perry et al., 1978) and (ii) the surrounding cell layers
and the basement membrane are permeable to macro-
molecular complexes such as lipoproteins, VTG, and others
(Hummel et al., 2004, 2007). These properties are compat-
ible with bulk (or “ﬂuid phase”) uptake of yolk precursors,
which are present at high concentrations in the serum.
Thus, this process, which occurs at high rate due to the
large surface of the oocyte, may  be characteristic of the
earlier phase of oocyte growth, i.e., up to the largest size
of oocytes seen in R/O ovaries (Fig. 1). In this scenario,n Science 136 (2012) 1– 13
however, LR8 is envisioned to be essential for comple-
tion of oocyte growth. Receptor-mediated endocytosis is
a process in which the concentration of receptor ligands
in the target cell reaches levels that exceed by several-fold
that in the extracellular ﬂuid (Goldstein and Brown, 2009),
whereas in bulk ﬂuid uptake, there is a simple linear rela-
tionship. Importantly, again different from nonspeciﬁc bulk
uptake, the receptor-mediated pathway allows the uptake
of speciﬁc components that have high afﬁnity for the recep-
tors. Together, these features of yolk precursor uptake via
LR8 may  be critical for the maturation of oocytes. In any
case, ovulation of oocytes that have not reached the ﬁnal
mature state can occur, possibly explaining the observa-
tions (Ho et al., 1974; Jones et al., 1975; Birrenkott and
McGibbon, 1975; Schjeide et al., 1976; Mitchell et al., 1979;
Grau et al., 1979; Cho, 1981; Michel et al., 1984; Smith and
Kummerow, 1988; Elkin et al., 2003b; Giles et al., 2010,
Table 1 and Fig. 2) that (i) R/O hens occasionally lay eggs,
and (ii) these eggs are smaller. The second, alternative or
additional, explanation for early phase R/O oocyte growth
is that at least in the early stages of yolk uptake, endo-
cytic receptor(s) other than LR8 may  perform this task. One
proposed candidate for such a role is a 380-kDa protein
with many hallmark properties of yolk precursor binding
proteins (Stifani et al., 1991; Bujo et al., 1997). Interest-
ingly, as determined by quantitative PCR, the mRNA level
for this protein termed LRP380, which is localized within,
or closely associated with, the oocyte plasma membrane
is 11-times higher in the ovarian stroma of R/O hens than
of normal hens (T. Zarrabi, Diploma Thesis, University of
Vienna, 2002; and D. Raich, unpublished). This increase
may  be a compensatory mechanism for the LR8 defect in
R/O hens. However, although LRP380 contains sequences
with high homology to signature domains typical of LRs
(Stifani et al., 1991; Nimpf et al., 1994), it has not been
shown directly to be competent for internalization of lig-
ands, nor has its complete structure been delineated (WJS,
personal communication). Therefore, further studies are
needed to ascertain the physiological and biochemical roles
of LRP380 in oocyte growth.
In addition to providing exciting molecular insights into
the biology of R/O hens (see also Section 6), the delineation
of the mutation facilitated the development of a rapid
PCR-based genotyping procedure for the identiﬁcation of
mutant alleles in R/O animals (Fig. 4; Bujo et al., 1996; Elkin
et al., 2003b). Needing only microliter amounts of blood
(red cells, which in avians are nucleated), this rapid and
accurate procedure eliminated the need for conventional
progeny testing while reducing the time needed to identify
R/O carrier males and mutant females from approximately
one year to two  days or less.
The biological role of chicken LR8 in the laying hen is
thus unambiguously documented by both biochemical and
genetic evidence (Bujo et al., 1995b; Nimpf et al., 1989).
As described above, LR8 mediates a key step in the repro-
ductive effort of the hen, i.e., normal oocyte growth. With
respect to R/O roosters (Section 3), Elkin and Zhong (2002)
concluded that only one normal allele for the LR8 gene
is sufﬁcient for optimal male reproductive performance.
Accordingly, they suggested that LR8 production from the
WT allele is able to compensate for the failure of the mutant
R.G. Elkin et al. / Animal Reproductio
Fig. 4. PCR ampliﬁcation of genomic DNA from wild-type (WT)
and ‘restricted ovulator’ (R/O) chickens. The PCR-ampliﬁed fragments
obtained from 150 ng of genomic DNA isolated from erythrocytes were
generated using primer pairs speciﬁc for the WT (Lanes 1, 3, 5, and 7) or
the  mutant very low density lipoprotein receptor genes (Lanes 2, 4, 6, and
8), respectively. The PCR-ampliﬁed products were subjected to agarose
gel electrophoresis as described by Bujo et al. (1996).  Lanes 1 and 2: WT
female; Lanes 3 and 4: mutant R/O female; Lanes 5 and 6: WT male; and
Lanes 7 and 8: mutant R/O carrier male. Lanes M contain as size markers
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llele to produce a normal gene product (i.e., the male phe-
otype, if any, is inherited as a recessive trait).
Interestingly, those tissues which express the VLDLR in
ammals (i.e., heart, skeletal muscle, brain, and adipose
issue, but not the liver), express LR8 in the chicken, albeit at
ery low levels (approx. 0.5%) as compared to the oocytes.
hile mammals and somatic cells of the chicken express
ainly a longer splice variant of VLDLR/LR8, chicken
ocytes apparently express only the shorter isoform (Bujo
t al., 1995a).
From these results, the following conclusions can be
rawn. Oocytic LR8 is a multifunctional receptor, which
ransports lipoproteins and other components required for
mbryonic growth into the yolk (Schneider et al., 1998).
he larger variant produced by somatic cells likely per-
orms similar functions in mammals and oviparous species,
s they express this isoform in the same tissues. The physio-
ogical properties of LR8 strengthen the view (Steyrer et al.,
990) that the avian receptor is the product of an ancient
ene that has retained the ability to interact with many,
f not all, ligands of younger members of the LR family.
n this context, VTG, absent from therians, and apoE, not
ound in birds, have certain common biochemical proper-
ies and regions of sequence similarities, and have been
uggested to be functional analogues (Steyrer et al., 1990).
hus, triglyceride-rich particles could be transported into
etabolically active tissues (such as muscle, where VLDLR
s abundant), while in avian oocytes VTG and VLDL are
aken up to provide nutrients and energy for the developing
mbryo.
. Other metabolic or physiological characteristics
f mutant R/O hens
.1. Tissue and plasma lipids and lipogenic enzyme
ctivitiesWhen averaged across all studies reported to date that
mployed sexually mature birds aged 6 mo  and older, R/O
ens had approximately 4.5-, 4.4-, and 4.9-times greatern Science 136 (2012) 1– 13 7
circulating levels of total cholesterol, phospholipids, and
triglycerides, respectively, as compared with WT  hens,
and approximately 6-, 18-, and 56-fold higher levels,
respectively, as compared with WT  roosters (Table 2).
Cho (1981) determined the plasma fatty acid proﬁles
of cholesteryl esters, phospholipids, and triglycerides in
normal layers and in R/O hens as they aged from 17 to 34
wk of age. Palmitic acid was  the predominant circulating
saturated fatty acid, while oleic and linoleic acids were the
main unsaturated fatty acids. However, as the hens aged,
no consistent trends in individual fatty acid concentra-
tions were observed across the three lipid classes or two
genotypes (Cho, 1981).
R/O hens also generally have greater body weights (BW)
and larger livers, both on an absolute and relative BW
basis, that contain more total cholesterol and crude fat,
and less crude protein, than those of WT  hens or WT
roosters (Ho et al., 1974; Ho, 1976; Mitchell et al., 1979;
Fitch et al., 1982; Cho, 1983; Qureshi et al., 1983; Elkin
et al., 2006). Moreover, as compared with normal lay-
ers, R/O hens exhibit elevated hepatic contents of myristic
acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid,
linoleic acid, arachidonic acid, and docosahexaenoic acid,
on both a relative and a total organ basis (Elkin et al., 2006).
Qureshi et al. (1983) measured the hepatic, intesti-
nal, and adipose tissue activities of two  key enzymes
of cholesterol metabolism (discussed in Section 5.2),
as well as various lipogenic enzymes, including fatty
acid synthase, glucose-6-phosphate dehydrogenase, 6-
phosphogluconate dehydrogenase, malic enzyme, and
citrate cleavage enzyme. When expressed on a cytosolic
mass basis, the activities of all of the lipogenic enzymes in
each tissue were depressed in R/O hens as compared with
normal layers. Qureshi et al. (1983) concluded that the liver
is the primary site for lipogenesis and cholesterogenesis in
the chicken. Cho (1983) also observed markedly reduced
rates of lipogenesis in R/O hens as evidenced by very low
levels of incorporation of radiolabeled acetate and meval-
onate into lipids. In contrast to normal laying hens, neither
compound was  readily oxidized to CO2.
5.2. Cholesterol metabolism and VLDL turnover rates
In contrast to marked differences in circulating choles-
terol levels in normal layers and R/O hens (Table 2), the
total cholesterol content of heart and other tissues is gener-
ally similar between genotypes (Ho, 1976; Cho et al., 1984).
Cho et al. (1984) therefore suggested that a large portion of
endogenous cholesterol pool in R/O hens is conﬁned mainly
to the circulatory system, as opposed to being deposited in
the tissues. A notable exception was  the aorta, which is
the main site of atherosclerotic lesions in the laying hen
(discussed in Section 5.3).
Based on the results of a kinetic study of cholesterol
metabolism, Ho et al. (1974) concluded that the hypercho-
lesterolemia exhibited by R/O hens was  not caused by the
overproduction of cholesterol, but was  mainly due to the
failure to sufﬁciently remove cholesterol from the body
via “excretion” in egg yolks. They also reported that, as
compared with WT  hens, R/O hens had attenuated rates of
endogenous cholesterol synthesis and a much slower daily
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Table 2
Plasma total lipids of sexually mature (>6 mo)  wild-type (WT) hens, restricted ovulator (R/O) hens, and WT roosters.a
Lipids Cholesterol Phospholipids Triglycerides
(mg/100 mL)
WT  hens Avg 159 694 1513
SD  91 288 1045
Range 84–439 540–1021 570–3792
R/O  hens Avg 717 3041 7421
SD 211 1783 3674
Range 455–1380 910–4800 1777–13840
WT  roosters Avg 110 172 131
SD  26 15 65
Range 79–157 160–189 39–229
et al. (19
. (1985, a Data from Ho et al. (1974), Ho (1976), Schjeide et al. (1976), Mitchell 
et  al. (1983), Cho et al. (1984, 1987),  Leszczynski et al. (1984), Smith et al
turnover of cholesterol. Nimpf et al. (1989) conﬁrmed the
latter ﬁnding by demonstrating that the plasma clearance
of intravenously injected 125I-VLDL was markedly impaired
in R/O hens compared with WT  hens. They also observed
attenuated levels of radioactivity in oocytes from R/O hens
compared with those from WT  hens. Based on ligand bind-
ing experiments with 125I-VLDL, Nimpf et al. (1989) also
provided the ﬁrst biochemical evidence that the receptor
for VLDL was absent in R/O oocytes and suggested that this
defect was responsible for the R/O phenotype (described in
Section 4).
Ho et al. (1974) reported that, as compared with
normal layers, R/O hens had a 6-fold increase in the
size of the plasma cholesterol pool and a 55% reduc-
tion in the rate of total cholesterol synthesis. This led
Mitchell et al. (1979) to examine the activities of 3-
hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR)
and cholesterol 7-hydroxylase, the rate-limiting enzymes
for biosyntheses of cholesterol and bile acids, respectively.
Mitchell et al. (1979) observed that hepatic HMGR activi-
ties in 26-wk-old R/O hens were only between 12% and 25%
of those of immature (18-wk-old) hens, while the activity
of this enzyme increased by more than 2-fold in 26-wk-
old WT  hens (Mitchell et al., 1979). Because the circulating
cholesterol levels in nonlayers were ﬁve times greater than
those of normal layers, Mitchell et al. (1979) attributed the
low HMGR activities in R/O hens to the feedback inhibition
of cholesterol biosynthesis. These investigators also found
that after maturation, cholesterol 7-hydroxylase activi-
ties were decreased in both WT  and R/O hens, which was
most likely due to the decreased availability of cholesterol
substrate pools for bile acid synthesis (Mitchell et al., 1979).
Fitch et al. (1982) and Qureshi et al. (1983) also observed
lower HMGR and cholesterol 7-hydroxylase activities in
R/O hens compared with WT  hens. Paradoxically, Cho et al.
(1987) reported that R/O hens had a daily fecal bile acid
excretion rate that was twice as great as in normal layers.
They suggested that this was an adaptive change, albeit
inadequate, of R/O hens to normalize plasma cholesterol
concentrations in response to their extreme hyperlipi-
demia. Cho et al. (1987) also concluded that there was  a
lack of a relationship between egg laying capacity and the
rate of daily fecal neutral steroid excretion, since the latter
was similar in R/O and WT  hens.79), Toda et al. (1980, 1981),  Tokuyasu et al. (1980),  Cho (1981), Qureshi
1987),  Smith and Kummerow (1988, 1989), Elkin et al. (2003b, 2006).
HMGR inhibitors, commonly referred to as statins, are
widely used in human medicine to lower plasma LDL-
cholesterol levels and have also been shown to be effective
plasma and egg cholesterol-lowering agents when fed to
normal laying hens (Elkin et al., 1999, 2003a). Since mutant
R/O hens exhibit plasma cholesterol levels that are approx-
imately 5-fold higher than WT  hens (described in Section
5.1), Elkin et al. (2006) examined the effects of orally
administered atorvastatin on plasma and liver cholesterol
contents and the expression of several key genes regu-
lating cholesterol and VLDL metabolism in R/O and WT
hens. Atorvastatin lowered plasma cholesterol levels by
approximately 60% in WT hens and by 45% in R/O hens;
however, the statin treatment did not completely normal-
ize the blood lipid levels of the R/O females. Expression
of several key genes involved in VLDL assembly (such as
apolipoprotein B, the large subunit of microsomal triglyc-
eride transfer protein, and protein disulﬁde isomerase)
were suppressed in R/O hens compared with WT  hens,
but were unaffected by atorvastatin treatment. In contrast,
hepatic HMGR mRNA levels were elevated by atorvastatin
in both WT  and R/O hens, but only WT  hens exhibited an
atorvastatin-mediated increase in liver HMGR immunore-
active protein levels (Elkin et al., 2006). The reason why R/O
hens responded less strongly than WT  hens to atorvastatin
treatment may  lie in the fact that their hepatic HMGR gene
expression and/or translation was  down-regulated due to
higher baseline levels of circulating cholesterol.
5.3. Atherosclerotic lesions and tissue oxidative stress
Chickens have been a valuable animal model for the
study of atherosclerosis (Toda et al., 1983; St. Clair, 1998;
Ayala et al., 2005). This condition develops naturally in
their aortas and coronary arteries and at an accelerated
rate when the birds are fed cholesterol-containing diets
(St. Clair, 1998). Moreover, atherosclerotic lesions from
cholesterol-fed chickens have cholesterol crystal inclu-
sions, as evidenced by cholesterol clefts (spaces caused
by the dissolving out of cholesterol crystals in sections
of tissue embedded in parafﬁn; Stedman’s, 2006), foam
cells (monocyte-derived macrophages ﬁlled with modiﬁed
lipids), and a ﬁbromuscular cap, all of which are character-
istics of human lesions (St. Clair, 1998).
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Ho et al. (1974) were the ﬁrst to report that R/O
ens developed moderate to severe aortic atherosclero-
is after 18 months of endogenous hyperlipidemia (i.e.,
hen birds are approximately 2 years of age). Lesions typ-
cally contained a conglomeration of yellow plaques while,
icroscopically, thickened intima containing lipid-laden
oam cells, together with large amounts of mucopolysac-
harides, were observed. Ho et al. (1974) found no evidence
f ulceration, calciﬁcation, or thrombosis of atherosclerotic
laques, although the aortas of R/O hens contained much
reater amounts of cholesterol than those of WT  hens or
oosters. In a subsequent study, Ho (1976) conﬁrmed this
atter ﬁnding. Tokuyasu et al. (1980) examined aortas from
- to 3-yr-old WT  and R/O hens and found that lesions
eveloped earlier and were more extensive and fatty in the
/O hens compared with the normal layers. However, stain-
ble lipids in the aortic lesions increased with age in both
roups. Moreover, Tokuyasu et al. (1980) observed that in
/O hens, the ascending thoracic and abdominal aorta were
he most extensively and consistently diseased, with inti-
al  lesions in the latter section containing foam cells, large
ools of glycosaminoglycans, cholesterol clefts, extracel-
ular lipid droplets up to 25 m in diameter, and smooth
uscle cells containing various amounts of lipids.
Toda et al. (1980) examined the coronary arteries of
ormal layers, R/O hens, and roosters and observed that
ost lesions were found in the proximal portion of both
he left and right coronary arteries. The severity and speed
f development of coronary atherosclerosis was highly
orrelated with the degree of hyperlipidemia. Ultrastruc-
urally, the arterial lesions contained thickened intima with
 plethora of foam cells and smooth muscle cells. Toda et al.
1981) subsequently conducted a light- and electron micro-
copic evaluation of aortas, coronary arteries, and superior
esenteric arteries from 3- to 7-yr-old roosters, WT hens,
nd R/O hens. Only mild pathological changes were noted
n roosters as compared with layers and non-layers (R/O
ens), with R/O hens exhibiting the most severe lipid-rich
ortic lesions and the greatest degree of intimal thickening
n the coronary and superior mesenteric arteries. Lesions
n the latter two arteries were similar to those described
y Toda et al. (1980).
Oxidized lipids, particularly oxidized LDL, are thought
o initiate and modulate the inﬂammatory cellular events
n the arterial wall and the formation of macrophage
oam cells (Nosadini and Tonolo, 2011). Toda et al. (1983)
bserved large amounts of peroxidized lipids in both
lasma and aortic tissue of R/O hens. Likewise, Smith et al.
1985) reported that, as compared with normal 1-yr-old
aying hens, R/O hens exhibited extreme hyperlipidemia
ith increased levels of peroxidized plasma lipids. How-
ver, when expressed on the basis of triglyceride or
hospholipid, there were no differences in the extent
f plasma peroxidation. Smith and Kummerow (1988,
989) supplemented the diets of WT  and R/O hens with
000 IU/kg diet of vitamin E, reported to function inter-
ellularly and intracelluarly as an antioxidant (McDowell,
000). Supplemental dietary vitamin E had no effect on
he circulating levels of cholesterol or triglycerides in R/O
ens, which were each approximately 10-fold higher than
n WT  hens. In contrast, vitamin E reduced plasma lipidn Science 136 (2012) 1– 13 9
peroxidation (determined by quantiﬁcation of malondi-
aldehyde) and aortic intimal thickness more than 4-fold
in R/O hens, resulting in similar levels to those in WT
hens. Smith and Kummerow (1988, 1989) concluded that
serum lipid peroxidation was of greater importance than
hyperlipidemia in the atherosclerotic process, since hyper-
lipidemic hens with normal serum peroxide levels showed
no aortic intimal thickening. It should be pointed out that
in man, despite strong biological and observational data,
more rigorous scientiﬁc evaluation has not supported a
causative relationship between dietary vitamin E and/or
vitamin C supplements and a lowering of coronary artery
disease risk (Tinkel et al., 2012).
5.4. Bone characteristics and egg yolk mineral
composition
The laying hen skeleton contains cortical, trabecular,
and medullary bone (Kim et al., 2004). The latter, which
is located in the marrow cavity of most long bones (e.g.,
tibia and femur), is formed shortly before the onset of lay
under the inﬂuence of estrogen and testosterone (Johnson,
2000). During the hen’s 24–28-hr ovulation-oviposition
cycle, medullary bone is resorbed and supplies approx-
imately 35–40% of the daily calcium needs for eggshell
formation (Comar and Driggers, 1949; Mueller et al., 1964);
hens fed a high-calcium diet are generally able to restore
medullary bone and calcium reserves when shell formation
is not taking place (Johnson, 2000).
Since R/O hens typically lay few, if any, eggs in their
lifetimes, Michel et al. (1984) took advantage of this char-
acteristic in order to investigate whether physiological
factors associated with egg production inﬂuenced the level
of ﬂuorine (F) deposition in the tibias of R/O and WT hens
fed diets containing either 27 ppm F or 282 ppm F. They
observed almost 2-fold greater tibial F contents in WT  lay-
ers compared with R/O hens fed either diet, and 5-fold
higher F levels due to dietary F supplementation for each
genotype. Michel et al. (1984) suggested that once dietary F
had been deposited into bones, it was less readily resorbed
than calcium and became more concentrated over time,
thus resulting in higher bone F levels in WT  hens.
Kim et al. (2004) assessed the bones of WT,  R/O and
out-of-production (OP) hens; unlike non-laying R/O hens,
the latter do not display secondary sex characteristics. As
compared with WT  and OP hens, R/O hens had higher cir-
culating calcium concentrations, greater humerus, femur,
and tibia ash contents, and higher bone mineral contents
and densities as determined by dual-energy X-ray absorp-
tion. R/O females also exhibited extremely dense femur
medullary bone deposition, as determined by gross and
histological assessments. Kim et al. (2004) concluded that
R/O hens have a higher bone density than WT  or OP hens
due to intensive medullary bone formation and the lack of
a cyclic calcium metabolism as a consequence of grossly
diminished egg shell formation.
Grau et al. (1979) examined the ring structure and rel-
ative iron content of yolks by freezing intact eggs from
R/O and W/T  hens, ﬁxing them with formalin, cutting them
in half and then staining one half with potassium dichro-
mate and the other half with acidic potassium ferrocyanide.
roductio10 R.G. Elkin et al. / Animal Rep
Yolks from R/O eggs stained less intensely with acidic fer-
rocyanide than WT  yolks, suggesting that they contained
relatively less iron. Mineral analyses performed by atomic
absorption spectrophotometry revealed that R/O egg yolks
contained less iron and copper, similar levels of phospho-
rus, and more sodium and potassium than egg yolks from
WT  hens (Grau et al., 1979). In addition, the yolk granule
fraction of R/O eggs contained less iron and manganese
than those from WT  layers.
Iron in yolk is bound primarily to phosvitin, which
is derived from circulating VTG following its intraoocytic
processing by cathepsin D (Retzek et al., 1992). Grau et al.
(1979) concluded that the ro gene may  interfere with nor-
mal  iron absorption, metabolism, or utilization leading to
both hyperlipidemia and low-iron eggs. Since the hyper-
lipidemia in R/O hens results from a single gene defect not
directly related to iron metabolism (described in Section 4),
it is plausible that either proportionately less VTG and/or
VTG carrying less iron, are delivered to the yolk of growing
oocytes of R/O hens. However, the yolk protein proﬁles of
eggs from WT  and R/O hens analyzed by SDS-PAGE (Fig. 3)
do not support the ﬁrst possibility.
6. Studies in which the R/O strain has contributed
to clarifying biological questions
6.1. The chicken LDL receptor
Molecular characterization of the chicken LDLR was
achieved 9 years after that of LR8 (Hummel et al., 2003);
the difﬁculties in obtaining full-length cDNA were due to
its low levels of expression and the sluggish regulation by
sterols in comparison to LDLRs in mammalian species. In
contrast to LR8, which is expressed and functions essen-
tially only in growing female germ cells, the chicken LDLR is
ubiquitously expressed. Its main physiologic role in mam-
mals is to supply somatic cells with cholesterol. However,
in chickens, this function is less important in peripheral tis-
sues, as these appear to satisfy their demand for cholesterol
primarily via intracellular biosynthesis and, as a conse-
quence, LDLR levels are low in e.g., cultured ﬁbroblasts
(Hummel et al., 2003). Accordingly, induction of LDLR levels
in-vitro requires not only the absence of sterols from the
culture medium, but also suppression of cellular choles-
terol synthesis (see Section 5.2). Of particular interest in
this context was the question of whether in steroidogenic
tissues, cellular biosynthesis would sufﬁce to supply the
amounts of cholesterol required for conversion to steroids,
or if a contribution by LDL taken up via the LDLR is required.
Thus, the levels of LDLR protein were analyzed in adrenal
glands and ovarian stroma of WT  and R/O hens (Fig. 3 in
Hummel et al., 2003). Interestingly, the LDLR levels were
higher in the adrenals than in the ovary of animals of both
genotypes, with the highest levels observed in the adrenals
of WT  hens. This indicated that: (i) chicken adrenal glands
utilize cholesterol delivered via the LDLR cholesterol in
addition to the intracellularly produced sterol; (ii) the ele-
vated plasma cholesterol in R/O hens reduces the required
contribution by the LDLR; and (iii) the hyperestrogenemia
in R/O hens does not lead to induction of LDLR in steroido-
genic tissues. However, estrogen administration to roostersn Science 136 (2012) 1– 13
increased hepatic LDLR levels signiﬁcantly, and a similar
difference was observed in the livers of untreated roost-
ers versus mature WT  hens (Hummel et al., 2003). Thus,
the R/O hen provided additional insight into regulatory and
physiological aspects of the LDLR in the chicken.
6.2. Endophilins in oocyte growth
The R/O hen has also been used as a tool in a study
of important molecules, the endophilins, which are part
of the accessory machinery of endocytic receptors such as
LR8 (Hirayama et al., 2003). In general, endophilins have
a prominent support function in processes that require
remodeling of the membrane structure, such as the invagi-
nation of the plasma membrane during clathrin-mediated
endocytosis (Kjaerulff et al., 2011). In the study of the three
isoforms of endophilin (I-III) involving R/O hens, it was
shown for the ﬁrst time that endophilin III is the main iso-
form in oocytes, and endophilin II predominates in the cells
of the follicular wall. Subsequently, the question was raised
whether diminished yolk precursor uptake by R/O oocytes
might be accompanied by an altered level of endophilin III.
The results showed that the absence of LR8 function in R/O
hens correlated with reduced levels of endophilin III in folli-
cles harboring growing oocytes, but not in brain, compared
to the levels in these tissues of WT  hens (Hirayama et al.,
2003). Thus, by utilizing the R/O hen in this study, it could
be shown that oocytic endophilin III levels correlate with
endocytic activity. However, upregulation of endophilin III
does not appear to be a mechanism for compensation of
receptor dysfunction in R/O hens.
6.3. Phospholipid transfer protein
In the circulation, phospholipid transfer protein
(PLTP) transfers phospholipids from the surface of
triacylglyceride-rich lipoproteins (such as VLDL) towards
high density lipoprotein (HDL) particles during intravas-
cular lipolysis (Albers et al., 2012). Chicken PLTP, ﬁrst
molecularly characterized in 2009 (Saarela et al., 2009),
performs the function of remodeling HDL particles in a
fashion reminiscent of its mammalian counterparts. How-
ever, given the signiﬁcantly different lipoprotein classes in
birds, in particular between mature roosters and hens, it
was  of interest to include the R/O hen as a further tool in
a study of the functional properties of PLTP in the chicken.
The PLTP activity in plasma of adult R/O hens was twice
as high as that in mature and immature WT  hens, adult
WT roosters, and adult R/O roosters. Chicken PLTP is found
primarily on HDL particles, which lack apoE as well as
apoA-II, apolipoproteins that have been implicated in the
distribution of PLTP among mammalian lipoprotein par-
ticles (Kärkkäinen et al., 2002). In this context, a second
important function of HDL-associated PLTP is to increase
the rate of cholesterol efﬂux from cells by HDL, the so-
called reverse cholesterol transport pathway. This activity
is determined by measuring the cholesterol released into
the medium of cholesterol-loaded cells in the presence of
the acceptor (Vikstedt et al., 2007). Interestingly, the most
active cholesterol acceptor in this system was  found to be
HDL of mature R/O hens, which was  twice as efﬁcient as
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uman HDL3, previously the best known acceptor. This
hysiologically beneﬁcial property is possibly related to
he comparatively low amount of free cholesterol in the
/O HDL particles, since it is not inﬂuenced by their tri-
cylglycerol content (Saarela et al., 2009). Despite their
ramatically hyperlipidemic status and propensity of R/O
ens to develop lipid-rich aortic lesions (see Section 5.3),
eports of death attributed to total arterial blockage(s) do
ot appear in the literature (see Section 5.3). This fact
ight possibly be explained by the high PLTP and efﬂux-
timulating activity of the plasma of R/O hens. Moreover,
n the late 1990s, it was  observed by RGE (unpublished)
hat there may  be a subpopulation of R/O hens that die at a
aster rate than their WT  siblings within the ﬁrst year of life,
ut that those hens which survive thereafter exhibit mor-
ality rates that are similar to WT  hens. Thus, it is tempting
o speculate that such hens may  be protected by higher
ndogenous PLTP activities than the ones that die dur-
ng the ﬁrst year. In summary, the experiments with R/O
ipoproteins in investigations of chicken PLTP have facil-
tated insights of pathophysiological relevance that could
ot have been obtained in WT  hens.
. Relationship of the R/O phenotype to another
odel of compromised female fertility: The
atanabe Heritable Hyperlipidemic (WHHL) Rabbit
Due to a functional deﬁciency caused by a mutation in
he LDLR gene, the WHHL rabbit is a widely used animal
odel for human autosomal dominant familial hyper-
holesterolemia, which is also caused by mutations in
he LDL receptor gene, and atherosclerosis (Shiomi and
to, 2009). However, its reproductive ability is markedly
ower than that of normal rabbits (Shiomi et al., 1987;
ortensen and Frandsen, 1996) and abnormalities have
een found in both sexes (Donnelly et al., 1991). For exam-
le, losses at ovulation, implantation, and during gestation
ave been reported in female WHHL rabbits, while males
xhibited poor sperm morphology and motility (Donnelly
t al., 1991). Robins et al. (1994) suggested that the LDL
eceptor defect in WHHL rabbits might contribute to their
ower fecundity by attenuating steroidogenesis, as a result
f reduced transport of cholesterol ester-rich LDL into
teroid-producing cells. In concert with this hypothesis,
HHL rabbits exhibit decreased plasma estrogen levels
Robins et al., 1994). In addition, WHHL rabbits also had
igher baseline plasma LH and FSH concentrations as com-
ared with New Zealand White (NZW) rabbits (Robins et al.,
994), which putatively resulted from a lack of negative
eedback inhibition from the ovary (Chappell et al., 1999).
owever, in contrast to the report of Donnelly et al. (1991),
obins et al. (1994) did not observe decreased concentra-
ions of circulating progesterone at baseline or during the
rst 8 days of pseudopregnancy in WHHL rabbits, as com-
ared to control NZW rabbits, and concluded that there
as a compensatory source of cholesterol for progesterone
teroidogenesis during the preovulatory period and in early
seudopregnancy.
Although WHHL female rabbits and mutant R/O
ens each have defective LDL receptor supergene fam-
ly members, elevated circulating gonadotropins, andn Science 136 (2012) 1– 13 11
are reproductively dysfunctional, they exhibit markedly
divergent plasma ovarian steroid proﬁles. Therefore,
the mechanisms underlying the etiology of the abnor-
mal  hypothalamic-pituitary-ovarian axes in these unique
lipoprotein receptor-deﬁcient animal models are likely not
identical. Nevertheless, as our understanding of the molec-
ular physiology and biochemistry of avian oocyte growth
continues to expand, in part due to studies of the R/O model,
new analogies may  emerge between avian and mammalian
systems, which ultimately could help to answer important
questions in reproductive biology.
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